| Literature DB >> 34174278 |
Patricio Atanes1, Tanyel Ashik2, Shanta J Persaud3.
Abstract
G protein-coupled receptors (GPCRs) are a large family of cell surface receptors that are the targets for many different classes of pharmacotherapy. The islets of Langerhans are central to appropriate glucose homeostasis through their secretion of insulin, and islet function can be modified by ligands acting at the large number of GPCRs that islets express. The human islet GPCRome is not a static entity, but one that is altered under pathophysiological conditions and, in this review, we have compared expression of GPCR mRNAs in human islets obtained from normal weight range donors, and those with a weight range classified as obese. We have also considered the likely outcomes on islet function that the altered GPCR expression status confers and the possible impact that adipokines, secreted from expanded fat depots, could have at those GPCRs showing altered expression in obesity.Entities:
Keywords: Adipose; Diabetes; GPCRs; Human islets; Insulin secretion; Obesity
Mesh:
Substances:
Year: 2021 PMID: 34174278 DOI: 10.1016/j.pharmthera.2021.107928
Source DB: PubMed Journal: Pharmacol Ther ISSN: 0163-7258 Impact factor: 12.310